GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Abbott Laboratories (Pakistan) Ltd (KAR:ABOT) » Definitions » Cyclically Adjusted FCF per Share

Abbott Laboratories (Pakistan) (KAR:ABOT) Cyclically Adjusted FCF per Share : ₨24.41 (As of Mar. 2024)


View and export this data going back to 1982. Start your Free Trial

What is Abbott Laboratories (Pakistan) Cyclically Adjusted FCF per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

Abbott Laboratories (Pakistan)'s adjusted free cash flow per share for the three months ended in Mar. 2024 was ₨-7.384. Add all the adjusted free cash flow per share for the past 10 years together and divide the count will get our Cyclically Adjusted FCF per Share, which is ₨24.41 for the trailing ten years ended in Mar. 2024.

During the past 12 months, Abbott Laboratories (Pakistan)'s average Cyclically Adjusted FCF Growth Rate was -14.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted FCF Growth Rate using Cyclically Adjusted FCF per Share data.

As of today (2024-06-08), Abbott Laboratories (Pakistan)'s current stock price is ₨690.00. Abbott Laboratories (Pakistan)'s Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2024 was ₨24.41. Abbott Laboratories (Pakistan)'s Cyclically Adjusted Price-to-FCF of today is 28.27.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of Abbott Laboratories (Pakistan) was 27.87. The lowest was 11.74. And the median was 17.81.


Abbott Laboratories (Pakistan) Cyclically Adjusted FCF per Share Historical Data

The historical data trend for Abbott Laboratories (Pakistan)'s Cyclically Adjusted FCF per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Abbott Laboratories (Pakistan) Cyclically Adjusted FCF per Share Chart

Abbott Laboratories (Pakistan) Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted FCF per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - 29.68 25.38

Abbott Laboratories (Pakistan) Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted FCF per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 28.49 24.37 23.51 25.38 24.41

Competitive Comparison of Abbott Laboratories (Pakistan)'s Cyclically Adjusted FCF per Share

For the Drug Manufacturers - Specialty & Generic subindustry, Abbott Laboratories (Pakistan)'s Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Abbott Laboratories (Pakistan)'s Cyclically Adjusted Price-to-FCF Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Abbott Laboratories (Pakistan)'s Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Abbott Laboratories (Pakistan)'s Cyclically Adjusted Price-to-FCF falls into.



Abbott Laboratories (Pakistan) Cyclically Adjusted FCF per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

What is Cyclically Adjusted FCF per Share? How do we calculate Cyclically Adjusted FCF per Share?

Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted FCF per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the free cash flow per share from 2001 through 2010.

We adjusted the 2001 free cash flow per share data with the total inflation from 2001 through 2010 to the equivalent free cash flow in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's free cash flow is $1 a share in 2001, then the 2001's equivalent free cash flow in 2010 is $1.4 a share. If Wal-Mart's free cash flow is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 free cash flow in 2010 is $1.35. So on and so forth, you get the equivalent free cash flow per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Abbott Laboratories (Pakistan)'s adjusted Free Cash Flow per Share data for the three months ended in Mar. 2024 was:

Adj_FreeCashFlowPerShare= Free Cash Flow per Share /CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=-7.384/131.7762*131.7762
=-7.384

Current CPI (Mar. 2024) = 131.7762.

Abbott Laboratories (Pakistan) Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201406 6.464 100.560 8.471
201409 4.823 100.428 6.328
201412 10.725 99.070 14.266
201503 2.821 99.621 3.732
201506 9.913 100.684 12.974
201509 10.020 100.392 13.152
201512 6.563 99.792 8.666
201603 1.485 100.470 1.948
201606 0.782 101.688 1.013
201609 9.199 101.861 11.901
201612 10.312 101.863 13.340
201703 1.030 102.862 1.320
201706 18.775 103.349 23.939
201709 7.412 104.136 9.379
201712 15.273 104.011 19.350
201803 2.487 105.290 3.113
201806 -9.265 106.317 -11.484
201809 5.760 106.507 7.127
201812 7.067 105.998 8.786
201903 -16.615 107.251 -20.414
201906 0.246 108.070 0.300
201909 -13.041 108.329 -15.864
201912 8.052 108.420 9.787
202003 15.157 108.902 18.341
202006 17.581 108.767 21.300
202009 12.969 109.815 15.563
202012 23.336 109.897 27.982
202103 19.035 111.754 22.445
202106 26.066 114.631 29.965
202109 4.299 115.734 4.895
202112 9.465 117.630 10.603
202203 6.090 121.301 6.616
202206 -0.990 125.017 -1.044
202209 -16.542 125.227 -17.407
202212 13.609 125.222 14.321
202303 -18.542 127.348 -19.187
202306 -35.493 128.729 -36.333
202309 -2.368 129.860 -2.403
202312 24.247 129.419 24.689
202403 -7.384 131.776 -7.384

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.


Abbott Laboratories (Pakistan)  (KAR:ABOT) Cyclically Adjusted FCF per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted FCF per Share may underestimate the company's free cash flow. Cyclically Adjusted Price-to-FCF can seem to be too high even the actual Price-to-Free-Cash-Flow is low.

For the Cyclically Adjusted Price-to-FCF, the free cash flow per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/FCF calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted Price-to-FCF is also called CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.

Abbott Laboratories (Pakistan)'s Cyclically Adjusted Price-to-FCF of today is calculated as

Cyclically Adjusted Price-to-FCF=Share Price/Cyclically Adjusted FCF per Share
=690.00/24.41
=28.27

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of Abbott Laboratories (Pakistan) was 27.87. The lowest was 11.74. And the median was 17.81.


Be Aware

Cyclically Adjusted Price-to-FCF works better for cyclical companies. It gives you a better idea on the company's real free cash flow value.


Abbott Laboratories (Pakistan) Cyclically Adjusted FCF per Share Related Terms

Thank you for viewing the detailed overview of Abbott Laboratories (Pakistan)'s Cyclically Adjusted FCF per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Abbott Laboratories (Pakistan) (KAR:ABOT) Business Description

Traded in Other Exchanges
N/A
Address
Hyderabad Road, Landhi, P.O. Box 7229, Plot No. 258 & 324, Opposite Radio Pakistan Transmission Centre, Karachi, PAK, 75120
Abbott Laboratories (Pakistan) Ltd is engaged in manufacturing, importing, and marketing research-based pharmaceutical, nutritional, diagnostic, diabetes care, molecular devices, hospital, and consumer products. Its operating segments are Pharmaceutical, Nutritional, Diagnostics, and Others. It generates maximum revenue from the Pharmaceutical segment. Geographically, it derives the majority of its revenue from Pakistan and also has a presence in Afghanistan, Sri Lanka, Bangladesh, and Switzerland. Its Brands include Duphaston, Surbex Z, Serc, Duphala, Pediasur, Similac, and others.

Abbott Laboratories (Pakistan) (KAR:ABOT) Headlines

No Headlines